DEXA Scanning Remains the Gold Standard for Measuring Bone Density and Fracture Risk
A comprehensive review of DEXA technology explains how this low-radiation imaging tool diagnoses osteoporosis and guides longevity-focused bone health strategies.
Summary
Dual-energy X-ray absorptiometry (DEXA) has been the clinical gold standard for measuring bone mineral density since FDA approval in 1988. By emitting photons at two distinct energy levels, DEXA creates planar images that quantify bone mass in g/cm². Results are reported as T-scores and Z-scores — comparing a patient's bone density to young-adult and age-matched populations respectively. DEXA is favored over CT, MRI, and ultrasound due to its low cost, minimal radiation exposure, and fast scan times. Emerging opportunistic CT-based volumetric BMD measurements may expand screening reach by detecting asymptomatic osteoporosis in scans already performed for other reasons, complementing traditional DEXA workflows.
Detailed Summary
Bone mineral density (BMD) is a critical biomarker in longevity medicine, directly linked to fracture risk, mobility, independence, and all-cause mortality in aging adults. Osteoporosis often progresses silently until a fragility fracture occurs, making reliable early detection essential. This StatPearls review provides a thorough technical and clinical overview of dual-energy X-ray absorptiometry, the dominant diagnostic tool in this space.
DEXA works by positioning a C-arm beneath a supine patient and emitting photons at two distinct energy levels — one targeting soft tissue and one targeting cortical bone. A collimator minimizes scatter radiation, while detectors above the patient capture differential attenuation to produce a planar bone mass image measured in g/cm². The entire scan is brief, inexpensive, and exposes patients to significantly less radiation than CT or standard X-ray.
Results are interpreted using two standardized scores. The T-score compares the patient's BMD to the peak bone mass of a gender- and race-matched young adult population. A T-score at or below -2.5 defines osteoporosis. The Z-score compares BMD to age-matched peers, helping clinicians distinguish age-expected bone loss from pathological decline.
An emerging development highlighted in this review is opportunistic volumetric BMD assessment from routine CT scans. Measured in g/cm³, these readings correlate strongly with DEXA and could enable passive screening for asymptomatic osteoporosis in patients already undergoing imaging for unrelated conditions — potentially transforming detection rates at no added cost or radiation burden.
For longevity-focused clinicians and patients, DEXA remains the foundation of bone health monitoring. Its long-standing guidelines, accessibility, and proven accuracy make it indispensable for tracking bone aging and evaluating the impact of interventions such as resistance training, hormone therapy, and pharmacological treatments.
Key Findings
- DEXA has been the FDA-approved clinical standard for bone mineral density measurement since 1988.
- T-scores below -2.5 standard deviations from young-adult norms define osteoporosis diagnosis.
- DEXA offers lower radiation exposure and faster scan times than CT or MRI alternatives.
- Opportunistic CT-based volumetric BMD correlates well with DEXA and may expand asymptomatic screening.
- Z-scores compare patient BMD to age-matched peers, distinguishing normal aging from pathological loss.
Methodology
This is a narrative review chapter from StatPearls, a continuously updated medical reference. It synthesizes established clinical and technical literature on DEXA without conducting original experimental research or meta-analysis. The review covers physics, scoring methodology, regulatory history, and emerging CT-based alternatives.
Study Limitations
This review is based solely on the abstract of a textbook chapter, limiting access to full clinical nuances and cited evidence. StatPearls entries are educational rather than systematic reviews, so they may not reflect the most recent primary research. DEXA itself has limitations including inability to measure true volumetric density and susceptibility to artifacts from body composition and positioning.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: